These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 19915375)

  • 1. [Acute myeloid leukemia trials by Japan Adult Leukemia Study Group (JALSG)].
    Miyazaki Y
    Rinsho Ketsueki; 2009 Aug; 50(8):611-6. PubMed ID: 19915375
    [No Abstract]   [Full Text] [Related]  

  • 2. A phase-three trial comparing daunorubicin or idarubicin combined with cytosine arabinoside in acute myelogenous leukemia.
    Vogler WR; Velez-Garcia E; Omura G; Raney M
    Semin Oncol; 1989 Feb; 16(1 Suppl 2):21-4. PubMed ID: 2648581
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of acute myeloid leukemia--focusing on the data from JALSG studies].
    Miyawaki S
    Rinsho Ketsueki; 2008 Oct; 49(10):1386-93. PubMed ID: 18833923
    [No Abstract]   [Full Text] [Related]  

  • 4. A systematic collaborative overview of randomized trials comparing idarubicin with daunorubicin (or other anthracyclines) as induction therapy for acute myeloid leukaemia. AML Collaborative Group.
    Br J Haematol; 1998 Oct; 103(1):100-9. PubMed ID: 9792296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicenter trial of cytarabine plus idarubicin or daunorubicin as induction therapy for adult nonlymphocytic leukemia.
    Wiernik PH; Case DC; Periman PO; Arlin ZA; Weitberg AB; Ritch PS; Todd MB
    Semin Oncol; 1989 Feb; 16(1 Suppl 2):25-9. PubMed ID: 2928807
    [No Abstract]   [Full Text] [Related]  

  • 6. Idarubicin in acute leukemia: results of studies at Memorial Sloan-Kettering Cancer Center.
    Berman E; Raymond V; Gee T; Kempin SJ; Gulati S; Andreeff M; Kolitz J; Gabrilove J; Heller G; Young CW
    Semin Oncol; 1989 Feb; 16(1 Suppl 2):30-4. PubMed ID: 2928808
    [No Abstract]   [Full Text] [Related]  

  • 7. Idarubicin in acute leukemias: experience of the Italian Cooperative Group GIMEMA.
    Petti MC; Mandelli F
    Semin Oncol; 1989 Feb; 16(1 Suppl 2):10-5. PubMed ID: 2928805
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment for AML in first remission].
    Miyazaki Y
    Rinsho Ketsueki; 2010 Jul; 51(7):471-6. PubMed ID: 20693765
    [No Abstract]   [Full Text] [Related]  

  • 9. [Current therapy for acute myeloid leukemia and acute promyelocytic leukemia].
    Miyawaki S
    Rinsho Ketsueki; 2014 Jan; 55(1):31-41. PubMed ID: 24492035
    [No Abstract]   [Full Text] [Related]  

  • 10. Allogeneic versus autologous bone marrow transplantation versus chemotherapy for treatment of acute myeloid leukemia in first complete remission (BGM 84 and BGMT 87 studies). The BGMT Group.
    Reiffers J; Stoppa AM; Rigal-Huguet F; Michallet M; Marit G; Gastaut JA; Attal M; Corront B; Broustet A; Hollard D
    Bone Marrow Transplant; 1991; 7 Suppl 2():36. PubMed ID: 1878709
    [No Abstract]   [Full Text] [Related]  

  • 11. A randomized, postremission comparison of four courses of standard-dose consolidation therapy without maintenance therapy versus three courses of standard-dose consolidation with maintenance therapy in adults with acute myeloid leukemia: the Japan Adult Leukemia Study Group AML 97 Study.
    Miyawaki S; Sakamaki H; Ohtake S; Emi N; Yagasaki F; Mitani K; Matsuda S; Kishimoto Y; Miyazaki Y; Asou N; Matsushima T; Takahashi M; Ogawa Y; Honda S; Ohno R;
    Cancer; 2005 Dec; 104(12):2726-34. PubMed ID: 16284985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fetal liver infusion: an adjuvant in the therapy of acute myeloid leukemia (AML).
    Kochupillai V; Sharma S; Francis S; Mehra NK; Nanu A; Verma IC; Takkar D; Kumar S; Gokhale U
    Prog Clin Biol Res; 1985; 193():267-79. PubMed ID: 3911212
    [No Abstract]   [Full Text] [Related]  

  • 13. Results of the Italian AIEOP/LAM 8204 study for the treatment of childhood AML: an update.
    Amadori S; Mandelli F; Ceci A; Comelli A; Madon E; Masera G; Nespoli L; Paolucci G; Zanesco L; Defazio D
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():114-5. PubMed ID: 2653484
    [No Abstract]   [Full Text] [Related]  

  • 14. [A late phase II comparative study of idarubicin + cytarabine and daunorubicin + cytarabine in adult patients with acute non-lymphocytic leukemia. Idarubicin Study Group].
    Masaoka T; Ogawa M; Yamada K; Kimura K; Ohhashi Y
    Gan To Kagaku Ryoho; 1993 Oct; 20(13):1995-2005. PubMed ID: 8215474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of peripheral blood stem cells as rescue after myeloablative therapy.
    Reiffers J; Marit G; Boiron JM; Rice A; Bernard P; Vezon G
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():212-4. PubMed ID: 2565746
    [No Abstract]   [Full Text] [Related]  

  • 16. Tandem versus single autologous peripheral blood stem cell transplantation as post-remission therapy in adult acute myeloid leukemia patients under 60 in first complete remission: results of the multicenter prospective phase III GOELAMS LAM-2001 trial.
    Chevallier P; Fornecker L; Lioure B; Béné MC; Pigneux A; Recher C; Witz B; Fegueux N; Bulabois CE; Daliphard S; Bouscary D; Vey N; Delain M; Bay JO; Turlure P; Bernard M; Himberlin C; Luquet I; Ifrah N; Harousseau JL;
    Leukemia; 2010 Jul; 24(7):1380-5. PubMed ID: 20508614
    [No Abstract]   [Full Text] [Related]  

  • 17. FLAIE (fludarabine, cytarabine, idarubicin, and etoposide), a four drug induction chemotherapy for adult acute myeloid leukemia: A single center experience.
    Candoni A; Simeone E; Tiribelli M; Malagola M; Russo D; Fanin R
    Am J Hematol; 2009 Oct; 84(10):690-2. PubMed ID: 19731308
    [No Abstract]   [Full Text] [Related]  

  • 18. [Standard therapies for acute myeloid leukemia].
    Matsumura I
    Rinsho Ketsueki; 2009 Oct; 50(10):1389-400. PubMed ID: 19915347
    [No Abstract]   [Full Text] [Related]  

  • 19. Diffuse osteosclerosis-associated acute myeloid leukemia.
    Ward DE; Fondaw MB; Shroff SK; Reddy VS; Khaled YA
    J Clin Oncol; 2012 Jan; 30(1):e3-4. PubMed ID: 22124108
    [No Abstract]   [Full Text] [Related]  

  • 20. One versus two high-dose cytarabine-based consolidation before autologous stem cell transplantation for young acute myeloblastic leukaemia patients in first complete remission.
    Jourdan E; Rigal-Huguet F; Marit G; Vey N; Dastugue N; Fegueux N; Molina L; Gastaut JA; Legros L; Zerazhi H; Cailleres S; Bauduer F; Bordessoule D; Attal M; Blaise D; Pigneux A;
    Br J Haematol; 2005 May; 129(3):403-10. PubMed ID: 15842665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.